Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03915678
Title Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie

nasopharynx carcinoma

urinary bladder cancer

head and neck cancer


pancreatic cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

cervical cancer

Kaposi's sarcoma


Atezolizumab + BDB001

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.